Have a personal or library account? Click to login
Eudragit FS 30D as a potential polymer for use in the technology of preparing matrix tablets contain metronidazole – an experimental and mathematical modeling study Cover

Eudragit FS 30D as a potential polymer for use in the technology of preparing matrix tablets contain metronidazole – an experimental and mathematical modeling study

Current Issues in Pharmacy and Medical Sciences
Volume 28 (2015): Issue 2 (June 2015)
By:
Open Access
|Jul 2015

References

  1. 1. Brunton L.L., Lazo J.S., Parker K.L.: Goodman and Gilman’s: the pharmacological basis of therapeutics, 11th ed. New York: McGraw-Hill, 2006.
    Search in Google Scholar
  2. 2. Campos-Aldrete M.E., Villafuerte-Robles L.: Influence of the viscosity grade and particle size of HPMC on metronidazole release from matrix tablets. Eur. J. Pharm. Biopharm., 43, 173, 1997.
    Search in Google Scholar
  3. 3. Draper N.R., Smith H.: Applied Regression Analysis, John Wiley &amp; Sons Inc., 1998<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1002/9781118625590" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/9781118625590</a></dgdoi:pub-id>
    Search in Google Scholar
  4. 4. Evonik. Eudragit® Application Guidelines, http://eudragit.evonik.com/, 2009.
    Search in Google Scholar
  5. 5. Godfrey R., Edwards R.: A chromatographic and spectroscopic study of photo-degraded metronidazole in aqueous solution. J. Pharm. Sci., 80, 212, 1991.
    Search in Google Scholar
  6. 6. Gupta V.K. et al.: A novel pH- and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables. Int. J. Pharm., 213, 93, 2001.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/S0378-5173(00)00650-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S0378-5173(00)00650-5</a></dgdoi:pub-id>
    Search in Google Scholar
  7. 7. ICH Guideline. Q2 (R1) (2005) Validation of analytical procedures: text and methodology. International Conference on Harmonization. Vol. 6. 1996.
    Search in Google Scholar
  8. 8. Lehmann K., Dreher D.: Mischbarkeit wässriger Poly(meth) acrylat-Dispersionen für Arzneimittelüberzüge. Pharmaz. Ind., 48,1182,1986.
    Search in Google Scholar
  9. 9. Lindenberg M., Kopp S., Dressma J.B.: Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm., 58, 265, 2004.
    Search in Google Scholar
  10. 10. Moore J.W., Flanner H.H.: Mathematical comparison of curves with emphasis on in vitro dissolution profiles. Pharm. Techn., 20, 64, 1996.
    Search in Google Scholar
  11. 11. Moustafine R.I. et al.: Drug release modification by Interpolymer interaction between countercharged types of Eudragit RL 30D and FS 30D in double - layer films. Int. J. Pharm., 439,17, 2012. <dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/j.ijpharm.2012.09.044" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ijpharm.2012.09.044</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">23041129</dgpm:pub-id>
    Search in Google Scholar
  12. 12. Mustafin R.I.: Interpolymer Combinations of Chemically Complementary Grades of Eudragit copolymers: A new direction in the design of peroral solid dosage forms of drug delivery systems with controlled release (review). Pharm. Chem. J., 45, 285, 2011.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/s11094-011-0618-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s11094-011-0618-7</a></dgdoi:pub-id>
    Search in Google Scholar
  13. 13. Otsuka M., Matsuda Y.: Effect of co-grinding time on the release of pentoxyfylline from waxy matrix tablets. J. Pharm. Sci., 83, 956, 1994.
    Search in Google Scholar
  14. 14. Ozyazici M., Gökçe E.H., Ertan G.: Release and diffusional modelling of metronidazole lipid matrices. Eur. J. Pharm. Biopharm., 63, 331, 2006.
    Search in Google Scholar
  15. 15. Remington J.P.: Remington: The science and practice of pharmacy. Eds. David B. Troy, and Paul Beringer. Vol. 1. Lippincott Williams &amp; Wilkins, electronic version. London: Pharmaceutical Press, 2006.
    Search in Google Scholar
  16. 16. Sato H. et al.: Dissolution mechanism of diclofenac sodium from wax matrix granules. J. Pharm. Sci., 86, 929, 1997.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1021/js960221w" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1021/js960221w</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">9269871</dgpm:pub-id>
    Search in Google Scholar
  17. 17. Serra L., Domenech J., Peppas N.A.: Drug transport mechanism and release kinetics from molecularly designed poly(acrylic acid-gethylene glycol) hydrogels. Biomaterials, 27, 5440, 2006.
    Search in Google Scholar
  18. 18. Shi D. (ed.). Biomedical devices and their applications. Springer, 2004.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/978-3-662-06108-4" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/978-3-662-06108-4</a></dgdoi:pub-id>
    Search in Google Scholar
  19. 19. Siepmann J., Peppas N.A.: Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev., 48, 139, 2001.
    Search in Google Scholar
  20. 20. Szente V, Baska F, Zelkó R, Suvegh K. Prediction of the drug release stability of different polymeric matrix tablets containing metronidazole. J. Pharm. Biomed. Anal., 54(4): 730-4, 2011.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/j.jpba.2010.11.005" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jpba.2010.11.005</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">21129883</dgpm:pub-id>
    Search in Google Scholar
  21. 21. The Merck Index. Fourteenth Edition, Whitehouse Station, NJ: Merck &amp; Co., electronic version, 2006.
    Search in Google Scholar
  22. 22. United States Pharmacopoeia/National Formulary, 32/27, Rockville, MD: Pharmacopeial Convention; 2009
    Search in Google Scholar
  23. 23. Viridén A. et al.: Model drug release from matrix tablets composed of HPMC with different substituent heterogeneity. Int. J. Pharm., 401, 60, 2010.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/j.ijpharm.2010.09.017" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ijpharm.2010.09.017</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">20883761</dgpm:pub-id>
    Search in Google Scholar
  24. 24. Viridén A., Wittgren B., Larsson A.: Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets. Eur. J. Pharm. Sci., 36, 297, 2009.
    Search in Google Scholar
  25. 25. Zhang Y. et al.: DDSolver: An add-in program for modeling and comparison of drug dissolutions profiles. AAPS J, 12, 263, 2010.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1208/s12248-010-9185-1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1208/s12248-010-9185-1</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">2895453</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">20373062</dgpm:pub-id>
    Search in Google Scholar
DOI: https://doi.org/10.1515/cipms-2015-0053 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 97 - 104
Submitted on: May 8, 2015
Accepted on: Jun 2, 2015
Published on: Jul 16, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Eudragit FS,
matrix tablets,
metronidazole
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2015 Tomasz Letmanski, Anna Kodym, Piotr Weber, Michal Lewandowski, Andrzej Wisniewski, Tomasz Baj, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 28 (2015): Issue 2 (June 2015)Next article